Our free daily oncology focused e-news service.

Oncology Clinical News

SELLAS Life Sciences’ Phase 2 Results for Galinpepimut-S in High-Risk Multiple Myeloma Presented at European Society for Blood and Marrow Transplantation Meeting

(Pharmavoice.com) Mar 19, 2018 - SELLAS Life Sciences Group, Inc. today announced the presentation of open label Phase 2 clinical and immunological data for its lead cancer immunotherapeutic candidate, galinpepimut-S (GPS), in the treatment of high-risk multiple myeloma at the 44th Annual European Society for Blood and Marrow Transplantation (EBMT) Meeting.

read article

Helsinn Group Announces First Patient Enrolled in Phase 3b Study of NEPA IV vs NEPA Oral for the prevention of chemotherapy induced nausea and vomiting (CINV) in Women with Breast Cance

(Morningstar) Mar 20, 2018 - Helsinn today announced that the first patient has been enrolled in a Phase 3b study to assess the safety and tolerability of IV NEPA fixed combination of fosnetupitant/palonosetron (235 mg/0.25 mg) compared to oral NEPA for the prevention of CINV in women with breast cancer receiving multiple cycles of anthracycline-cyclophosphamide (AC) chemotherapy.

read article

For Cancer, Cannabis Has Many Virtues, Says Large Study

(Medscape Medical News) Mar 19, 2018 - Cannabis, or marijuana, may improve a variety of cancer-related symptoms, including nausea and vomiting, sleep disorders, pain, anxiety, and depression, conclude the authors of a 2960-patient observational study from Israel.

read article (free registration required)

Scientists Caution That A Rare Childhood Liver Cancer Can Spread To The Brain

(The Rockefeller University) Mar 13, 2018 - A new report details three cases of secondary brain tumors in people with fibrolamellar hepatocellular carcinoma. The researchers say imaging tests could improve treatment for patients whose cancer spreads to the brain from the liver.

read article

Oncology Business and Policy News

NCCN Guidelines Recommend Optune in Combination with Temozolomide as a Category 1 Treatment for Newly Diagnosed Glioblastoma

(Markets Insider) Mar 20, 2018 - NovoCure announced today that the National Comprehensive Cancer Network (NCCN) has updated its clinical practice guidelines to recommend Optune® in combination with temozolomide as a category 1 treatment for newly diagnosed glioblastoma (GBM) in its globally recognized Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers.

read article

First Opinion: Getting Past The Bad Blood Of Theranos Through Collaboration

(STAT) Mar 16, 2018 - What’s the silver lining for those of us in the field? The Theranos saga set the stage for an unprecedented level of collaboration and data-sharing across companies working to develop liquid biopsy technologies.

read article

Innovation in Cancer Care Delivery—What’s in the Way?

(ACCCBuzz Blog) Mar 19, 2018 - What is the greatest opportunity for innovation to ensure that cancer care will be accessible, affordable, and convenient?

read article

Medicare ACO Enrollment Improves Quality of Breast, Colorectal Cancer Screening

(Journal Of Clinical Pathways) Mar 20, 2018 - Widespread use of alternative payment models may improve the quality of breast and colorectal cancer screening programs, according to an investigation published in JAMA Internal Medicine (online March 19, 2018; doi:10.1001/jamainternmed.2017.8087).

read article